Roelof Rongen

Company: Adolore BioTherapeutics

Job title: CEO

Seminars:

Foundations for Commercializing Gene Therapies: Key Activities for Successful Transition to Common Disease Markets 1:00 pm

• Identify core activities to adapt manufacturing, supply chains, and distribution models for larger patient populations • Develop effective market access strategies, including pricing, reimbursement, and partnerships, to ensure a smooth entry into common disease markets • Understand regulatory requirements and navigate challenges for scaling up gene therapy from rare to widespread applications while maintaining…Read more

day: Focus Day

Roundtable: Overcoming the Challenges and & Maximizing Opportunities for Gene Therapy in Common Diseases 10:00 am

• Tackling the technical, regulatory, and financial barriers to gene therapy adoption in widespread conditions • Strategies to optimize manufacturing processes and reduce costs while maintaining efficacy and quality for larger populations • Identifying market access opportunities and pathways to ensure successful commercialization and patient accessRead more

day: Focus Day